The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation
Abstract
Aims To explore the therapeutic effect and possible mechanism of exosomes from MSCs overexpressing miR-223 on cerebral ischemia and microglia polarization mediated inflammation. Main methods Rats after middle cerebral artery occlusion and reperfusion (MCAO/R) surgery and microglia BV-2 exposed to oxygen and glucose deprivation (OGD) and cysteinyl leukotrienes (CysLTs) stimulation were subject to exosomes from miR-223-3p transfected MSCs treatment, respectively. Behavioral tests were applied to assess the rats' neurological function. FACS was used to analyze M1/M2 microglia BV-2. production of cytokines in the ischemic hemisphere and BV-2 was detected by ELISA or qRT-PCR. Western blotting and qRT-PCR were also used to examine the expression of cysteinyl leukotriene receptor 2 (CysLT 2 R) in vivo and in vitro. Key findings Exosomes from MSCs over expressing miR-223-3p decreased MCAO/R induced cerebral infarct volume, improved neurological deficits, promoted learning and memorizing abilities. They suppressed pro-inflammatory factors expression and promoted anti-inflammatory factors secretion in the ischemic cortex and hippocampus. In vitro, exosomal miR-223-3p exhibited a more evident impact on modulating mRNA expression and protein production of cytokines. It promoted M2 microglia transformation of M1 microglia induced by NMLTC 4 with a concentration-dependent manner. Western blot and qRT-PCR also revealed exosomal miR-223-3p decreased mRNA and protein expression of CysLT 2 R i…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, many reports have shown that miRNA can regulate gene expression at the translational level and thus affect the microglial phenotype (Zhao et al. 2020).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Zhao et al. 2020
In the citing paper
“By suppressing the M1 polarization of microglia, miR-223 alleviates pro-inflammatory reactions and reduced brain ischemia-reperfusion injury [63].”
From miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1 (2024) · cites this paper as [63]
Citations
Cites
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Guo, S., Perets, N., Betzer, O., Ben-Shaul, S., Sheinin, A., Michaelevski, I., Popovtzer, R., Offen, D., & Levenberg, S. (2019) · ACS Nano · doi:10.1021/acsnano.9b01892 · Cited by 424
Research works printed but not linked: 27
- Tan, 2019, Anti-Neuroinflammatory effect of Alantolactone through the suppression of the NF-κB and MAPK signaling pathways, Cells., 18, 7
- Geloso, 2017, The dual role of microglia in ALS: mechanisms and therapeutic approaches, Front. Aging Neurosci., 9, 242, 10.3389/fnagi.2017.00242 · DOI
- Sasaki, 2019, The leukotriene receptors as therapeutic targets of inflammatory diseases, Int. Immunol., 31, 607, 10.1093/intimm/dxz044 · DOI
- Wang, 2019, Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases, Neurobiol. Aging, 87, 1, 10.1016/j.neurobiolaging.2019.12.013 · DOI
- Zhang, 2018, Exosome-mediated small RNA delivery: a novel therapeutic approach for inflammatory lung responses, Mol. Ther., 26, 2119, 10.1016/j.ymthe.2018.06.007 · DOI
- Mathew, 2019, Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion, Biomaterials, 197, 146, 10.1016/j.biomaterials.2019.01.016 · DOI
- Thomi, 2019, Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury, Stem Cell Res Ther, 10, 105, 10.1186/s13287-019-1207-z · DOI
- Zhao, 2020, MSCs-derived exosomes attenuate acute brain injury and inhibit microglial inflammation by reversing CysLT2R-ERK1/2 mediated microglia M1 polarization, Neurochem. Res., 45, 1180, 10.1007/s11064-020-02998-0 · DOI
- Stoeck, 2006, A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44, Biochem. J., 393, 609, 10.1042/BJ20051013 · DOI
- Chen, 1992, The effect of hypothermia on transient middle cerebral artery occlusion in the rat, J. Cereb. Blood Flow Metab., 12, 621, 10.1038/jcbfm.1992.86 · DOI
- Longa, 1989, Reversible middle cerebral artery occlusion without craniectomy in rats, Stroke, 20, 84, 10.1161/01.STR.20.1.84 · DOI · Paper page
- Chen, 2001, Therapeutic benefit of intravenous administration of bone marrow stromal cells aftercerebral ischemia in rats, Stroke, 32, 1005, 10.1161/01.STR.32.4.1005 · DOI
- Liu, 2018, Icariin and mesenchymal stem cells synergistically promote angiogenesis and neurogenesis after cerebral ischemia via PI3K and ERK1/2 pathways, Biomed. Pharmacother., 108, 663, 10.1016/j.biopha.2018.09.071 · DOI
- Bieber, 2019, Validity and reliability of neurological scores in mice exposed tomiddle cerebral artery occlusion, Stroke, 50, 2875, 10.1161/STROKEAHA.119.026652 · DOI
- Xian, 2019, Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice, Theranostics, 9, 5956, 10.7150/thno.33872 · DOI
- Zhang, 2015, Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury, J. Neurosurg., 122, 856, 10.3171/2014.11.JNS14770 · DOI · Paper page
- Mulcahy, 2014, Routes and mechanisms of extracellular vesicle uptake, J Extracell Vesicles, 4, 3
- Samanta, 2018, Exosomes: new molecular targets of diseases, Acta Pharmacol. Sin., 39, 501, 10.1038/aps.2017.162 · DOI
- Ailawadi, 2015, Pathologic function and therapeutic potential of exosomes in cardiovascular disease, Biochim. Biophys. Acta, 1852, 1, 10.1016/j.bbadis.2014.10.008 · DOI
- Ismail, 2013, Macrophage microvesicles induce macrophage differentiation and miR-223 transfer, Blood, 121, 984, 10.1182/blood-2011-08-374793 · DOI
- Wang, 2015, Exosomal miR-223 contributes to mesenchymal stem cell-elicited cardioprotection in polymicrobial sepsis, Sci. Rep., 5
- Ifergan, 2016, Cutting edge: MicroRNA-223 regulates myeloid dendritic cell-driven Th17 responses in experimental autoimmune encephalomyelitis, J. Immunol., 196, 1455, 10.4049/jimmunol.1501965 · DOI
- Li, 2019, Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1, Autophagy, 15, 478, 10.1080/15548627.2018.1522467 · DOI · Paper page
- Shi QJ, Wang H, Liu ZX, Fang SH, Song XM, Lu YB, Zhang WP, Sa XY, Ying HZ4, Wei EQ. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats. Neuroscience. 2015; 291: 53–69. · DOI
- Zhang, 2013, HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation, J. Pharmacol. Exp. Ther., 346, 328, 10.1124/jpet.113.203604 · DOI
- Zhao, 2011, Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats, Neuroscience, 189, 1, 10.1016/j.neuroscience.2011.05.066 · DOI
- Hamzei Taj, 2016, MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia, Biomaterials, 91, 151, 10.1016/j.biomaterials.2016.03.025 · DOI · Paper page
Cited by
Sorted by citations
Ou, Z., Cheng, Y., Ma, H., Chen, K., Lin, Q., Chen, J., Guo, R., Huang, Z., Cheng, Q., Alaeiilkhchi, N., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05480-5 · Cited by 23
MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis
Asl, E. R., Hosseini, S. E., Tahmasebi, F., Bolandi, N., & Barati, S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01578-6 · Cited by 19
Metadata
- Authors
- Zhao, Y., Gan, Y., Xu, G., Hua, K., & Liu, D.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 260
- Pages
- 118403
- ISSN
- 0024-3205
- Cited by
- 134
- References
- 2
- Language
- en
- Licence
- Funders
- Natural Science Foundation (LY18H090011, LGF20H110001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation. https://app.cochat.ai/papers/10.1016/j.lfs.2020.118403
- The paper
- Zhao, Y., Gan, Y., Xu, G., Hua, K., & Liu, D. (2020). Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation. Life Sciences. https://doi.org/10.1016/j.lfs.2020.118403